secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2026-07-30T20:05:40+00:00
Accession:  0001606498-26-000115
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIP completes acquisition of Avanos for $1.272B; stockholders receive $25.00/share cash
--------------------------------------------------------------------------------

- Deal valued at ~$1.272B; Avanos stockholders get $25.00 per share in cash.
- Avanos common stock delisted from NYSE; company becomes private.
- New board: David Pacitti CEO, Scott Galovan CFO, John Fischer General Counsel.
- Credit agreement: $675M term loan, $100M DDTL, $100M revolver, matures 2033.
- Prior directors resigned; Joel Rotroff (AIP) initially appointed then replaced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000115/0001606498-26-000115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000115/avns-20260727.htm
  HTML page:      https://secwatch.observer/filing/0001606498-26-000115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer